683 Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-60,000
| Closed | -$1.26M | – | 152 |
|
|
2023
Q2 | $1.26M | Sell |
60,000
-330,000
| -85% | -$6.91M | 0.09% | 83 |
|
|
2023
Q1 | $8.24M | Sell |
390,000
-180,000
| -32% | -$3.8M | 0.61% | 40 |
|
|
2022
Q4 | $14.5M | Sell |
570,000
-560,000
| -50% | -$14.3M | 1.23% | 25 |
|
|
2022
Q3 | $27.2M | Sell |
1,130,000
-451,653
| -29% | -$10.9M | 2.1% | 10 |
|
|
2022
Q2 | $30.4M | Hold |
1,581,653
| – | – | 2.15% | 10 |
|
|
2022
Q1 | $27.5M | Buy |
1,581,653
+186,161
| +13% | +$3.24M | 1.47% | 12 |
|
|
2021
Q4 | $30.5M | Buy |
1,395,492
+259,592
| +23% | +$5.68M | 1.12% | 12 |
|
|
2021
Q3 | $21.7M | Buy |
1,135,900
+50,000
| +5% | +$955K | 0.85% | 25 |
|
|
2021
Q2 | $18.6M | Buy |
1,085,900
+250,900
| +30% | +$4.31M | 0.64% | 34 |
|
|
2021
Q1 | $18.7M | Sell |
835,000
-153,406
| -16% | -$3.43M | 0.99% | 23 |
|
|
2020
Q4 | $22M | Buy |
988,406
+160,035
| +19% | +$3.56M | 1.04% | 17 |
|
|
2020
Q3 | $12.2M | Sell |
828,371
-188,000
| -18% | -$2.77M | 0.9% | 22 |
|
|
2020
Q2 | $15.1M | Buy |
1,016,371
+83,333
| +9% | +$1.23M | 1.21% | 17 |
|
|
2020
Q1 | $10.2M | Buy |
933,038
+8,038
| +0.9% | +$88.2K | 1.2% | 19 |
|
|
2019
Q4 | $8.12M | Sell |
925,000
-246,648
| -21% | -$2.17M | 0.93% | 19 |
|
|
2019
Q3 | $8.75M | Sell |
1,171,648
-444,307
| -27% | -$3.32M | 0.97% | 20 |
|
|
2019
Q2 | $15M | Buy |
1,615,955
+17,598
| +1% | +$164K | 1.37% | 14 |
|
|
2019
Q1 | $8.39M | Buy |
1,598,357
+255,518
| +19% | +$1.34M | 0.76% | 24 |
|
|
2018
Q4 | $5.98M | Buy |
1,342,839
+821,839
| +158% | +$3.66M | 0.36% | 29 |
|
|
2018
Q3 | $4.21M | Buy |
521,000
+146,000
| +39% | +$1.18M | 0.27% | 39 |
|
|
2018
Q2 | $2.63M | Buy |
375,000
+91,770
| +32% | +$644K | 0.18% | 55 |
|
|
2018
Q1 | $4.03M | Buy |
+283,230
| New | +$4.03M | 0.36% | 43 |
|